FY26 Results: Core Profit Jumps 40%, Board Recommends ₹5 Dividend
Strides Pharma Science Limited · STAR · NSE ·
📈 **Strong Core Performance:** Profit After Tax from continuing operations surged 40.3% YoY to ₹5,745 million, driven by a 6.4% rise in revenue. 💰 **Dividend Proposed:** The Board has recommended a final dividend of ₹5 per equity share for the financial year ended March 31, 202…